MariMed Inc. (MRMD.CN)
CAD 0.15
(-11.76%)
CAD 0.15
(-11.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 65.91 Million USD | 3.07% |
| 2022 | 63.95 Million USD | -3.48% |
| 2021 | 66.26 Million USD | 111.53% |
| 2020 | 31.32 Million USD | 67.5% |
| 2019 | 18.7 Million USD | 139.43% |
| 2018 | 7.81 Million USD | 122.38% |
| 2017 | 3.51 Million USD | 58.76% |
| 2016 | 2.21 Million USD | 6696.83% |
| 2015 | -33.53 Thousand USD | 67.05% |
| 2014 | -101.78 Thousand USD | -301.01% |
| 2013 | -25.38 Thousand USD | -32.45% |
| 2012 | -19.16 Thousand USD | -118.68% |
| 2011 | 102.58 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 16.9 Million USD | 2.65% |
| 2024 Q1 | 16.47 Million USD | -4.88% |
| 2023 Q2 | 16.37 Million USD | 6.42% |
| 2023 Q4 | 17.31 Million USD | 2.84% |
| 2023 Q1 | 15.38 Million USD | -2.68% |
| 2023 Q3 | 16.83 Million USD | 2.82% |
| 2023 FY | 65.91 Million USD | 3.07% |
| 2022 Q1 | 16.97 Million USD | 9.59% |
| 2022 Q3 | 16.16 Million USD | 7.72% |
| 2022 Q4 | 15.81 Million USD | -2.18% |
| 2022 FY | 63.95 Million USD | -3.48% |
| 2022 Q2 | 15 Million USD | -11.61% |
| 2021 Q2 | 19.4 Million USD | 47.17% |
| 2021 Q4 | 15.49 Million USD | -14.8% |
| 2021 Q1 | 13.18 Million USD | 13.49% |
| 2021 FY | 66.26 Million USD | 111.53% |
| 2021 Q3 | 18.18 Million USD | -6.32% |
| 2020 FY | 31.32 Million USD | 67.5% |
| 2020 Q1 | 4.86 Million USD | 73.05% |
| 2020 Q2 | 6.15 Million USD | 26.5% |
| 2020 Q3 | 8.67 Million USD | 40.95% |
| 2020 Q4 | 11.61 Million USD | 33.86% |
| 2019 Q1 | 2.26 Million USD | -16.96% |
| 2019 Q4 | 2.81 Million USD | -40.15% |
| 2019 Q3 | 4.7 Million USD | -47.35% |
| 2019 FY | 18.7 Million USD | 139.43% |
| 2019 Q2 | 8.92 Million USD | 294.83% |
| 2018 Q2 | 2.02 Million USD | 69.5% |
| 2018 Q4 | 2.72 Million USD | 45.63% |
| 2018 Q1 | 1.19 Million USD | 274.01% |
| 2018 FY | 7.81 Million USD | 122.38% |
| 2018 Q3 | 1.86 Million USD | -7.62% |
| 2017 FY | 3.51 Million USD | 58.76% |
| 2017 Q4 | 319.26 Thousand USD | -74.82% |
| 2017 Q1 | 749.47 Thousand USD | -27.27% |
| 2017 Q2 | 1.24 Million USD | 66.16% |
| 2017 Q3 | 1.26 Million USD | 1.8% |
| 2016 Q1 | 298.22 Thousand USD | 192.54% |
| 2016 FY | 2.21 Million USD | 6696.83% |
| 2016 Q4 | 1.03 Million USD | 128.58% |
| 2016 Q3 | 450.82 Thousand USD | 4.16% |
| 2016 Q2 | 432.83 Thousand USD | 45.13% |
| 2015 Q1 | -12.31 Thousand USD | 87.06% |
| 2015 Q3 | 279.54 Thousand USD | 1200.33% |
| 2015 FY | -33.53 Thousand USD | 67.05% |
| 2015 Q4 | -322.26 Thousand USD | -215.28% |
| 2015 Q2 | 21.49 Thousand USD | 274.62% |
| 2014 Q4 | -95.15 Thousand USD | -4291.23% |
| 2014 FY | -101.78 Thousand USD | -301.01% |
| 2014 Q3 | -2167.00 USD | 0.51% |
| 2014 Q2 | -2178.00 USD | 4.39% |
| 2014 Q1 | -2278.00 USD | 52.41% |
| 2013 Q3 | -2648.00 USD | 80.32% |
| 2013 Q4 | -4787.00 USD | -80.78% |
| 2013 FY | -25.38 Thousand USD | -32.45% |
| 2013 Q1 | -4490.00 USD | 5.79% |
| 2013 Q2 | -13.45 Thousand USD | -199.71% |
| 2012 Q3 | -4581.00 USD | 13.5% |
| 2012 Q4 | -4766.00 USD | -4.04% |
| 2012 Q2 | -5296.00 USD | -17.17% |
| 2012 Q1 | -4520.00 USD | 0.0% |
| 2012 FY | -19.16 Thousand USD | -118.68% |
| 2011 Q2 | 48.21 Thousand USD | 0.0% |
| 2011 FY | 102.58 Thousand USD | 0.0% |
| 2011 Q3 | 14.66 Thousand USD | -69.59% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aion Therapeutic Inc. | -285.33 Thousand CAD | 23202.318% |
| Ayurcann Holdings Corp. | 8.46 Million CAD | -678.695% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -78165.361% |
| The BC Bud Corporation | 59.5 Thousand CAD | -110682.65% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -17608.403% |
| CordovaCann Corp. | 3.26 Million CAD | -1916.203% |
| Christina Lake Cannabis Corp. | 3.46 Million CAD | -1801.789% |
| Captor Capital Corp. | 16.93 Million CAD | -289.188% |
| City View Green Holdings Inc. | -290.73 Thousand CAD | 22772.991% |
| 1CM Inc. | 7.6 Million CAD | -766.364% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 19755.194% |
| IM Cannabis Corp. | 9.84 Million CAD | -569.5% |
| Lobe Sciences Ltd. | 772.82 Thousand CAD | -8429.604% |
| Maple Leaf Green World Inc. | -17.85 Thousand CAD | 369311.381% |
| Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 19151.734% |
| Nextleaf Solutions Ltd. | 1.24 Million CAD | -5184.249% |
| Ovation Science Inc. | -251.43 Thousand CAD | 26317.531% |
| Pharmadrug Inc. | -26.21 Thousand CAD | 251545.682% |
| Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -40234.206% |
| RAMM Pharma Corp. | -902.83 Thousand CAD | 7401.326% |
| RIV Capital Inc. | -958.27 Thousand CAD | 6978.902% |
| Revive Therapeutics Ltd. | -328.00 CAD | 20097356.098% |
| Red White & Bloom Brands Inc. | 29.48 Million CAD | -123.566% |
| SLANG Worldwide Inc. | 18.61 Million CAD | -254.034% |
| 1933 Industries Inc. | -602.75 Thousand CAD | 11036.23% |
| Red Light Holland Corp. | 2.02 Million CAD | -3162.561% |
| Top Strike Resources Corp. | 2.84 Million CAD | -2215.425% |
| Xebra Brands Ltd. | -367.96 Thousand CAD | 18014.524% |
| Adastra Holdings Ltd. | 7.03 Million CAD | -837.633% |